dorsaVi Limited (AU:DVL)
ASX:DVL
Want to see AU:DVL full AI Analyst Report?
DVL Stock Chart & Stats
AU$0.03
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.03
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.07
Previous CloseN/A
Volume925.00K
Average Volume (3M)8.34M
Market Cap
AU$43.56M
Enterprise ValueAU$49.64M
Total Cash (Recent Filing)AU$4.95M
Total Debt (Recent Filing)AU$135.68K
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Aug 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,210,028,400
10 Day Avg. Volume5,304,106
30 Day Avg. Volume8,343,384
Financial Highlights & Ratios
PEG Ratio1.57
Price to Book (P/B)3.65
Price to Sales (P/S)9.17
P/FCF Ratio-10.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage On Balance SheetA very low debt-to-equity ratio reduces financial distress risk and preserves borrowing capacity. Over 2-6 months this structural conservatism supports operational flexibility, ability to raise capital on better terms if needed, and limits fixed interest burden while pursuing growth.
Improving Gross Profit MarginAn improving gross margin suggests progress on product cost, pricing, or mix — a durable lever for profitability. If sustained, higher gross margins provide breathing room to absorb fixed operating costs and enable margin expansion as sales scale.
Exposure To Healthcare And Enterprise MarketsServing clinical, rehabilitation and workplace ergonomic customers links the business to structural trends in digital health, aging populations, and workplace safety. These persistent end-markets provide durable demand if product effectiveness and sales execution hold.
Bears Say
Declining Revenue TrendSustained revenue declines indicate weakening product adoption or competitive pressures and reduce scale benefits. Over months this erodes operating leverage, undermines reinvestment capacity, and makes achieving fixed-cost coverage and profitability substantially harder.
Negative Operating And Free Cash FlowPersistent negative operating and free cash flow represent ongoing cash burn that consumes liquidity and limits runway. Structurally, this forces reliance on external financing, constrains investment in product and sales, and raises execution and solvency risk over months.
Persistent Unprofitability And Negative MarginsConsistent negative profitability and ROE show the company cannot convert revenue into returns for shareholders. Without durable margin improvement or revenue recovery, losses will continue to erode equity and make attracting patient capital and scaling the business more difficult.
dorsaVi Limited News
DVL FAQ
What was dorsaVi Limited’s price range in the past 12 months?
dorsaVi Limited lowest share price was AU$0.01 and its highest was AU$0.07 in the past 12 months.
What is dorsaVi Limited’s market cap?
dorsaVi Limited’s market cap is AU$43.56M.
When is dorsaVi Limited’s upcoming earnings report date?
dorsaVi Limited’s upcoming earnings report date is Aug 21, 2026 which is in 76 days.
How were dorsaVi Limited’s earnings last quarter?
dorsaVi Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is dorsaVi Limited overvalued?
According to Wall Street analysts dorsaVi Limited’s price is currently Overvalued.
Does dorsaVi Limited pay dividends?
dorsaVi Limited does not currently pay dividends.
What is dorsaVi Limited’s EPS estimate?
dorsaVi Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does dorsaVi Limited have?
dorsaVi Limited has 1,210,028,400 shares outstanding.
What happened to dorsaVi Limited’s price movement after its last earnings report?
dorsaVi Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of dorsaVi Limited?
Currently, no hedge funds are holding shares in AU:DVL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
dorsaVi Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:DVL Sentiment 90%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
―
20 days / 200 days
Momentum
363.63%
12-Months-Change
Fundamentals
Return on Equity
-102.57%
Trailing 12-Months
Asset Growth
210.78%
Trailing 12-Months
Company Description
dorsaVi Limited
dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that tracks, analyzes, and reports how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes. It also offers ViPerform, a wearable and wireless movement sensor technology that offers objective data to assess risk of sport injury, and guides athletic training and recovery programs; telehealth solutions; and professional suites. dorsaVi Ltd was incorporated in 2008 and is based in Oakleigh South, Australia.
Technical Analysis
X2M Connect Limited
―
―
Hydrix Limited
―
Beam Communications Holdings Limited
―
ZIMI Ltd
―
Options Prices
Currently, No data available
---